Clinical Trials Logo

Filter by:
NCT ID: NCT02573116 Terminated - Clinical trials for Cardiovascular Disease in Obstructive Sleep Apnea

Impact of Treatment of Periodontis on Endothelial Function in Patients With Obstructive Sleep Apnea

EndothSAS
Start date: March 24, 2014
Phase: N/A
Study type: Interventional

Evaluation of the add-on effect on endothelial dysfunction of treatment of periodontitis in patients with chronic periodontitis and severe obstructive sleep apnea treated by CPAP. Patients with and without chronic periodontitis will be treated by CPAP for 20 weeks. At V2 (10 weeks), endothelial dysfunction will be assessed by the Reactive Hyperemia- Peripheral Artery Tone index. The endothelial dysfunction of the patients will be also assessed at V3 (20 weeks) after periodontitis treatment for the group of patients with chronic periodontitis.

NCT ID: NCT02570100 Terminated - Breast Cancer Clinical Trials

Research and Analysis of the Mechanisms Involved in the Emergence of Breast Cancer Stem Cells (RepriM)

Start date: April 2015
Phase: N/A
Study type: Interventional

From a cellular perspective, breast cancers appear to develop hierarchically from a small contingent of cancer stem cells (CSCs). The presence of CSCs in tumor tissue is associated with an increased risk of recurrence and metastasis, as well as a worse prognosis. Thus, these CSCs exhibit resistance to conventional anti-tumor treatments such as radiotherapy and chemotherapy. Moreover, these treatments would favor the emergence of these CSCs and the reprogramming of non-CSCs in CSCs. It has been demonstrated in neoadjuvant that the proportion of CSCs before any treatment is correlated with chemoresistance and that a resurgence of CSCs after chemotherapy is correlated with a poor prognosis. However, the mechanisms involved in the emergence of CSCs by reprogramming of non-CSCs are not yet known. The Oscar Lambret Center proposes a monocentric prospective interventional study based on the cellular and molecular analysis of the tumor, serum and circulating cells, before, during and at the end of the treatment for each patient receiving a neoadjuvant chemotherapy for breast cancer. The identification of the mechanisms contributing to the enrichment of CSCs resistant to chemotherapy could lead to therapeutic solutions.

NCT ID: NCT02568683 Terminated - Clinical trials for Non-Hodgkin Lymphoma

Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)

Start date: February 11, 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the safety of ENTO with VCR in participants with relapsed or refractory B-cell NHL.

NCT ID: NCT02568163 Terminated - Clinical trials for Chronic Periodontitis

Influence of Stress on Non Surgical Periodontal Treatment

Start date: September 2013
Phase: N/A
Study type: Interventional

Treatment of periodontal diseases is influenced by several risk factors. Psychological stress is considered as one of them. Aim of this study is to assess if stress influences results of non surgical periodontal treatment in severe chronic forms of periodontitis.

NCT ID: NCT02567279 Terminated - Anorexia Nervosa Clinical Trials

Impact of Denosumab in the Prevention of Bone Loss in Non-menopausal Women With Anorexia Nervosa

DIBLAN
Start date: June 1, 2016
Phase: Phase 3
Study type: Interventional

The drastic reduction of nutritional intake in anorexia nervosa(AN) alters many hormonal factors that regulate the activity of bone cells. This alteration of bone remodeling is characterized by increased bone resorption and decreased bone formation, leading to a marked reduction of bone mineral density, osteoporosis and an increased risk of fracture. To date, there is a paucity of studies and no consensus on the management of bone loss in patients with AN. The few previous studies were performed with small samples and using short follow-up periods. Denosumab is a fully human monoclonal antibody that binds with high specificity to human RANKL (6, 7), thereby reducing the number and activity of osteoclasts and therefore decreasing bone resorption that was found increased in patients AN. Denosumab may transiently protect bone whilst psychonutritional management will induce a weight restoration

NCT ID: NCT02566603 Terminated - Clinical trials for Immune Thrombocytopenia

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

Start date: November 2015
Phase: Phase 1/Phase 2
Study type: Interventional

Pre-clinical and clinical evaluations show that PRTX- 100 has biological activity that may lead to improved platelet levels where these are decreased due to immunological pathologies and that PRTX-100 has an acceptable safety profile. In vivo treatment with PRTX-100 has been shown to raise platelet counts in a mouse model of immune thrombocytopenia (ITP). The primary objective of the study is to assess the efficacy of PRTX-100 in terms of platelet response in patients with chronic/persistent ITP.

NCT ID: NCT02566382 Terminated - Clinical trials for Arthroscopy Arthrodesis Gleno-humeral

Preliminary Study of Feasibility of Arthrodesis Scapula-humeral Under Arthroscopy

DESEP
Start date: September 2015
Phase: N/A
Study type: Interventional

Arthrodesis shoulder blade/humerus under arthroscopy. Implementation of an external fixative spray at the proximal level in the thorn of the scapula and distal in the diaphysis humerus.

NCT ID: NCT02566122 Terminated - Muscle Strength Clinical Trials

Establishment of Normal Muscle Strength for French Population

Start date: January 2014
Phase:
Study type: Observational

Normal values for muscle strength using hand held dynamometer and muscle mass using echography are largely unknown. The objective of the present study is to establish normal values of these measurements in population living in France.

NCT ID: NCT02565433 Terminated - Neoplasm Metastases Clinical Trials

Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)

PRAMECE-1302
Start date: November 2013
Phase: N/A
Study type: Interventional

The aim of the study is to assess prospectively the impact of radiosurgery on the quality of life in patients with brain metastases.

NCT ID: NCT02565147 Terminated - Clinical trials for Acute Myocardial Infarction

Bivalirudin Infusion for Ventricular Infarction Limitation

BIVAL
Start date: December 19, 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate whether the use of bivalirudin will reduce extent of the damage done to the heart muscle in participants who suffered a heart attack, compared to the comparator treatment (heparin).